|
WO2015019253A2
|
|
Anti-dengue virus genetic vaccine based on the envelope protein ectodomains
|
|
WO2014184805A2
|
|
Biosensor for detection of mycothiol redox potential
|
|
US2014068818A1
|
|
Method for stable expression of suppressors of rnai in plants by direct genetic transformation of seeds
|
|
WO2013108272A2
|
|
Blood stage malaria vaccine
|
|
WO2013093870A1
|
|
microRNAs FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION
|
|
WO2014064707A1
|
|
Pichia pastoris -expressed dengue virus like particles
|
|
WO2013064934A1
|
|
A cellular model for the screening of tdp-43 aggregation affecting molecules
|
|
WO2012070008A2
|
|
Recombinant proteins with a selective inactivation activity on target proteins
|
|
WO2010061404A1
|
|
A method of expressing foreign protein in plastids
|
|
WO2010010501A1
|
|
Non-host transgenic plant comprising in its genome the entire genome of a badnavirus
|
|
WO2008152652A2
|
|
A dengue envelope domain iii-based tetravalent protein vaccine
|
|
WO2005056833A1
|
|
Molecular markers for mapping and tagging gm8 gene
|
|
WO2005055724A1
|
|
Biopesticidal compositions
|
|
WO2005026367A1
|
|
Overexpression of foreign genes in plants
|
|
WO2005014627A1
|
|
Recombinant dengue multi epitope proteins as diagnostic intermediates
|
|
EP1616011A2
|
|
Chimeric polypeptides and their use
|
|
AU2003249587A8
|
|
A method for screening a candidate substance as a potential drug for the treatment of malaria
|
|
EP1310559A1
|
|
Process for the production of alpha interferon of therapeutical degree
|
|
WO03033736A2
|
|
Fine mapping and application of dna markers linked to a gall midge resistance gene for marker-aided selection in rice
|
|
WO03010324A2
|
|
Process for the preparation of simvastatin
|
